HESTER BIOSCIENCES LTD
HESTERBIO · General/Diversified · NSE
₹1,496
Current Market Price
Fair Value (DCF)
₹893
Margin of Safety
-40.3%
Updated just now
YieldIQ Score
54/100
Piotroski F-Score
8/9
Economic Moat
Narrow
Confidence
41%
ROE
—
Debt/Equity
0.61
WACC
11.1%
Market Cap
₹1,273 Cr
Quality & Valuation
Neutral model outputs — no recommendations.
ROCE
—
Return on capital employed
EV / EBITDA
19.7×
Enterprise multiple
Debt / EBITDA
3.0×
Leverage vs earnings
Interest Coverage
—
EBIT covers interest
Current Ratio
—
Short-term liquidity
Asset Turnover
0.48×
Revenue per ₹ of assets
Revenue CAGR (3Y)
9.8%
3-year revenue growth
Revenue CAGR (5Y)
—
5-year revenue growth
DCF Scenario Analysis
vs CMP ₹1,496
Bear case
₹493.64
MoS -203.1%
Base case
₹893.34
MoS -67.5%
Bull case
₹1,202.06
MoS -24.5%
Ratio Trends
HESTERBIO · last 4 annual periods
ROE
8.4%
ROCE
12.0%
Operating Margin
—
Debt / Equity
0.65×
PE
48.7×
EV / EBITDA
23.6×
Historical Financials
HESTERBIO · Annual, last 4 years· amounts in ₹Cr unless noted
| Metric | 2022 | 2023 | 2024 | 2025 | CAGR |
|---|---|---|---|---|---|
| Revenue | ₹235 Cr | ₹266 Cr | ₹305 Cr | ₹311 Cr | +9.8% |
| EBITDA | ₹72.7 Cr | ₹66.0 Cr | ₹58.2 Cr | ₹64.7 Cr | -3.8% |
| EBIT | — | — | — | — | — |
| PAT | ₹39.3 Cr | ₹26.6 Cr | ₹18.9 Cr | ₹27.5 Cr | -11.2% |
| EPS (diluted) | — | — | — | — | — |
| CFO | ₹8.7 Cr | ₹23.6 Cr | ₹48.2 Cr | ₹64.5 Cr | +94.9% |
| CapEx | ₹-95.7 Cr | ₹-77.8 Cr | ₹-24.4 Cr | ₹-20.6 Cr | — |
| FCF | ₹-87.0 Cr | ₹-54.2 Cr | ₹23.8 Cr | ₹43.9 Cr | — |
| Total Assets | ₹562 Cr | ₹670 Cr | ₹662 Cr | ₹653 Cr | +5.1% |
| Total Debt | ₹228 Cr | ₹274 Cr | ₹244 Cr | ₹213 Cr | -2.2% |
| Shareholders' Equity | ₹267 Cr | ₹289 Cr | ₹303 Cr | ₹327 Cr | +6.9% |
CAGR computed across the visible window. Signs reverse if start value is zero or negative.
Peer Comparison
Peers not yet ranked for HESTERBIO. Comparable companies and side-by-side valuation will appear here once the peer set is established.
Dividend History
No dividend events recorded for HESTERBIO in the last 10 years.
AI Analysis Summary
Model-generated description of metrics. Not investment advice. HESTER BIOSCIENCES LTD (HESTERBIO.NS) trades at 1496.00 vs a model fair value of 893.34, a gap of -40.3%. Piotroski F-score: 8/9. Moat la...
Read full AI analysis →Reverse DCF
Market-implied growth
What FCF growth is priced in →
Risk Analysis
Volatility & drawdown
Risk profile of HESTERBIO →
DuPont
ROE decomposition
Why ROE is what it is →
Technicals
RSI, MACD, MAs
Reference indicators →
News & Filings
Recent activity
BSE filings + news for HESTERBIO →
Compare
Head-to-head with peers
Compare HESTERBIO side by side →
Run Full Interactive Analysis
Interactive DCF sliders, sensitivity heatmap, peer comparison, and more.
Analyse HESTERBIONow →Model estimates using publicly available data. Not investment advice. YieldIQ is not registered with SEBI as an investment adviser or research analyst. Past performance does not guarantee future results.